FDA

Today, Axoft revealed it has obtained the green light to initiate a pioneering human trial to test its innovative soft materials designed for brain-computer interfaces (BCIs). Hailing from Cambridge, Massachusetts, Axoft specializes in crafting soft substances that emulate the mechanical […]

In a recent announcement, the surgical tissue closure firm DuraStat revealed a new and exclusive U.S. commercial collaboration with a Medtronic unit. Rooted in Austin, DuraStat has joined forces with the Advanced Energy segment part of Medtronic’s Cranial and Spinal

Neuvotion has revealed an expansion of their partnership with Intelligent Product Solutions (IPS) as they work towards launching their neurostimulation product. This partnership includes a private investment from IPS’s parent organization, Forward Industries, intended to accelerate the introduction of their

BiVacor revealed today that it has successfully concluded the initial phase of an FDA-sanctioned early feasibility study (EFS) for its Total Artificial Heart (TAH). In this phase, the BiVacor TAH was implanted in five patients between July and November 2024,

ElectroCore, a company listed on the Nasdaq under the ticker ECOR, has announced its intentions to purchase NeuroMetrix, also traded on Nasdaq under NURO, along with its Quell neuromodulation technology. About the Quell Platform: NeuroMetrix has developed the Quell system—a

Moon Surgical revealed the induction of medtech expert Chris Toth as an independent board director. Toth, possessing over two decades of experience in advancing and managing commercial operations, brings deep knowledge in business acceleration. Currently, he holds the position of

CardioFocus recently announced the successful completion of the first set of treatments in the OptiShot pulsed-field ablation system study. This work is part of the VISION AF clinical trial, aiming to assess OptiShot’s efficiency in addressing paroxysmal AFib. Dr. Vivek

Smith+Nephew (NYSE: SNN) has officially secured FDA clearance for its innovative stemless anatomical total shoulder implant, part of the Aetos system. This new product answers the rising demand for anatomical total shoulder replacements, providing a compact solution that allows for

JenaValve shared that it has successfully conducted the initial patient procedure to join a registry dedicated to its Trilogy transcatheter heart valve (THV) system. JENA-VAD, serving as a forward-looking, multi-center, single-arm clinical registry, is a segment of the ALIGN-AR study.

BD (NYSE: BDX) Reaches Resolution with SEC Over Alaris Infusion System Investigation BD, the company headquartered in Franklin Lakes, New Jersey, has confirmed an agreement with the U.S. Securities and Exchange Commission (SEC) to conclude an inquiry into its Alaris